Amai Proteins

Amai Proteins

Private
IsraelHealthcare & Life Scienceshttps://www.amaiproteins.com

Last Round

Series A

Jan 10, 2023

Total Funding Raised

$117M

Momentum Score

25 /100

Company Overview

Amai Proteins is a food technology company that develops novel 'designer' proteins for the food and beverage industry. Its primary product is a hyper-sweet protein, marketed as 'sweelin™', designed to significantly reduce sugar in food products by up to 70% without compromising taste. The company utilizes a proprietary platform that combines Agile-Integrative Computational Protein Design (AI-CPD), precision fermentation, and food technology. This process involves redesigning proteins found in nature to enhance their stability and suitability for the mass food market, then producing them through a yeast-based fermentation process. Amai, which means 'sweet' in Japanese, aims to address global health issues like obesity and diabetes, as well as the environmental impact of sugar production. Beyond sweeteners, the company is also developing other designer proteins for meat, milk, and plant-based applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

sugar substitutesweet proteinsprecision fermentationcomputational protein designAI-CPDAI protein designsugar reductionfood techprotein engineeringalternative proteinsynthetic biologysynbiofood ingredient supplierfood formulationzero-calorie ingredient

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amai Proteins Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Amai Proteins Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 10, 2023
SeedApr 11, 2019

Key People

Founding team and executive leadership

ilan Samish

Founder, CEO

Founding Team

Moshe Hukaylo

Chief Financial Officer

Executive Team

Yigal Gezundhait

Chief Production Officer, COO

Executive Team

Amai Proteins Investors

Notable investors and investment history

Amai Proteins Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amai Proteins Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amai Proteins's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range58
Year Founded2016
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.